Retinoic Acids in the Treatment of Most Lethal Solid Cancers

Although the use of oral administration of pharmacological all-trans retinoic acid (ATRA) concentration in acute promyelocytic leukaemia (APL) patients was approved for over 20 years and used as standard therapy still to date, the same use in solid cancers is still controversial. In the present revi...

Descripción completa

Detalles Bibliográficos
Autores principales: Costantini, Lara, Molinari, Romina, Farinon, Barbara, Merendino, Nicolò
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073976/
https://www.ncbi.nlm.nih.gov/pubmed/32012980
http://dx.doi.org/10.3390/jcm9020360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073976/
https://www.ncbi.nlm.nih.gov/pubmed/32012980
http://dx.doi.org/10.3390/jcm9020360

Ejemplares similares